Duliege Anne-Marie 4
4 · RIGEL PHARMACEUTICALS INC · Filed Sep 19, 2018
Insider Transaction Report
Form 4
Duliege Anne-Marie
Chief Medical Officer
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2018-09-17−37,500→ 112,500 totalExercise: $2.11Exp: 2027-02-02→ Common Stock (37,500 underlying) - Sale
Common Stock
2018-09-17$3.50/sh−115,500$404,250→ 0 total - Exercise/Conversion
Employe Stock Option (right to buy)
2018-09-17−115,500→ 268,000 totalExercise: $2.54Exp: 2026-05-05→ Common Stock (115,500 underlying) - Exercise/Conversion
Common Stock
2018-09-17$2.54/sh+115,500$293,370→ 115,500 total - Exercise/Conversion
Common Stock
2018-09-17$2.11/sh+37,500$79,125→ 37,500 total - Sale
Common Stock
2018-09-17$3.50/sh−37,500$131,250→ 0 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2018.
- [F2]One fourth (1/4th) of the option vests one (1) year from March 7, 2016 and thereafter the balance of the option vests in equal monthly installments over the next thirty-six (36) months.
- [F3]The shares vest over four (4) years from January 1, 2017.